Thank you, Ted. As I typically do, I'll cover the following topics during this portion of the call. I'll cover an overview of our 2021 third quarter results, along with an overview of related key operating statistics. I'll cover an overview of our cash flow activities during the quarter, and I will then conclude with a discussion on our financial outlook for the fourth quarter of 2021. For purposes of this call, I will comment separately regarding the financial results of our Strategy and Business Transformation Group, or SMBT; our EPM ERP and Analytics Solutions Group, or EEA; our International Group and the total company. Our S&BT group includes the results of our North America IP-as-a-Service offerings, our executive advisory programs and benchmarking services and our business transformation practices. Our EEA Solutions group includes the results of our North America Oracle, SAP solutions and OneStream practices. Our International Group includes the results of our S&BT and our EEA resources that are based primarily in Europe. In addition, please note that all references to net revenues represent revenues excluding reimbursable expenses. Reimbursable expenses are primarily project travel-related expenses passed through to our clients and have no associated impact to our margin or profitability. Given the limited amount of business travel due to the pandemic, we encourage investors to focus on net revenues to assess revenue growth and margin trends. During our call today, we will reference certain non-GAAP financial measures, which we believe provide useful information to investors. We included reconciliations of GAAP to non-GAAP financial measures in our press release filed earlier today. Additionally, my comments today are based on results from continuing operations. For the third quarter of 2021, our net revenues increased to $71.4 million, up 24% when compared to the prior year, which is above the high end of our revenue guidance range. We continue to see an increase in client engagement throughout the quarter. This is also up 7% when you compare it to the pre-COVID third quarter of 2019. The Q3 reimbursable expense ratio on net revenues was 0.7% as compared to 0.3% when compared to the prior year. Reimbursable expenses have been significantly reduced in 2020 and 2021 due to COVID-19, which required the transition to a remote service delivery model. Our U.S. operations, which represented 92% of our total company net revenues in the third quarter of 2021 were up 27% when compared to the third quarter of the prior year. Net revenues for our S&BT Group were $27.6 million, an increase of 24% when compared to the same period in the prior year, reflecting the continued demand for enterprise digital transformation initiatives. Net revenues for our EEA Solutions group were $38.2 million, an increase of 29% when compared to the third quarter of the prior year. The year-over-year increase was driven by growth across all of our EEA practices. Net revenues for our International Group were $5.6 million, a decrease of 5% on a year-over-year basis as expected. Total company international net revenues accounted for 8% of total company net revenues as compared to 10% in the third quarter of the prior year. Our recurring revenues which include our executive advisory, IP as a service, multiyear benchmarks and AMS groups, accounted for approximately 19% of our total company net revenues and approximately 23% of our total company practice contributions in the quarter. Total company pro forma cost of sales, excluding reimbursable expenses, totaled $43.6 million or 61% of net revenues in the third quarter as compared to $37.8 million or 65.4% of net revenues in the previous year. Total company consultant headcount was 1,049 at the end of the third quarter as compared to total company consultant head count of 1,001 in the previous quarter and 923 at the end of the third quarter of 2020. The year-over-year increase was primarily a result of hiring activities and increased utilization of subcontractors resulting from higher demand. Total company pro forma gross margin on net revenues was 39% in the third quarter, up when compared to the prior year of 34.6%. S&BT gross margins on net revenues were 44.3% in the third quarter of 2021, up as compared to 42.4% in the third quarter of the prior year. The margin increase is primarily due to increased revenues partially offset by increased headcount and increased incentive compensation accruals commensurate with improving demand. EEA gross margins on net revenues were 34.9% in the third quarter up as compared to 27.5% in the third quarter of the prior year. The margin increase is primarily due to increased revenues, partially offset by incremental use of subcontractors and increased headcount commensurate with improving demand. International gross margins on net revenues were 41.4%, up as compared to prior year of 48.7%. The pro forma SG&A was $13.6 million or 19.1% of net revenues in the third quarter as compared to $12.7 million or 22% of net revenues in the prior year. The year-over-year absolute dollar increase is primarily due to increased sales commissions and incentive compensation accruals associated with increased company performance. Pro forma EBITDA was $15.1 million or 21.1% of net revenues in the third quarter as compared to $8.2 million or 14.1% of net revenues in the previous year, primarily resulting from increasing revenues. Total company pro forma net income for the third quarter of 2021 totaled $10.7 million or $0.32 per diluted share, which represents a year-over-year increase of 88% in pro forma diluted earnings per share and is above the high end of our guidance range. This compares to pro forma net income of $5.4 million or $0.17 per diluted share in the third quarter of 2020. Pro forma diluted earnings per share in the third quarter is up 19% when compared to the pre-COVID third quarter of 2019. GAAP diluted earnings per share was $0.25 in the third quarter of 2021 as compared to $0.09 in the third quarter of the previous year. The company's cash balances were $52.9 million at the end of the third quarter as compared to $52.5 million at the end of the previous quarter. Net cash provided by operating activities in the quarter was $6.8 million, which was primarily driven by net income adjusted for noncash activity, partially offset by increases in accounts receivable and decreases in accrued expenses and deferred revenues. Our DSO or day sales outstanding at the end of the quarter was 63 days as compared to 59 days at the end of the previous quarter. The company's $45 million credit facility remained unused during the third quarter of 2021. During the quarter, we repurchased 121,000 shares of the company's stock for an average of $18.74 per share at a total cost of approximately $2.3 million. Our remaining stock repurchase authorization at the end of the quarter was $11.5 million. At its most recent meeting, the company's Board of Directors declared the third quarterly dividend of $0.10 per share for shareholders of record on December 17, 2021, and to be paid on December 30, 2021. Before I move to guidance for the fourth quarter, I'd like to remind everyone of the seasonality of our business. Specifically, the increased holiday and vacation time that is historically taken in the fourth quarter will decrease our available billing days by approximately 8% when compared to the third quarter. As Ted mentioned in his comments, although economic uncertainty from the pandemic continues, the company's current estimates suggest that net revenue for the fourth quarter of 2021 will be in the range of $64.5 million to $66.5 million. We expect year-over-year total revenues to be up 9% to 12%, with all 3 practice areas also up. We estimate pro forma diluted earnings per share in the fourth quarter of 2021 to be in the range of $0.28 to $0.30. We expect pro forma gross margin on net revenues to be approximately 39% to 40%. We expect pro forma SG&A and interest expense for the fourth quarter to be approximately $13.5 million. We expect fourth quarter pro forma EBITDA on net revenues to be in the range of approximately 20% to 21%. We expect cash balances to be down sequentially, primarily due to net vesting activities associated with the expected settlement of outstanding stock appreciation rights, which expire in February of 2022. The company is settling these stock appreciation rates and equity and net vesting to satisfy the related tax obligations will result in the repurchase of approximately 1 million shares and will reduce the company's outstanding weighted average shares by approximately 3% in 2022 and will require approximately $21 million to $23 million of available cash balances. At this point, I would like to turn it back over to Ted to review our market outlook and strategic priorities for the coming months.